Winner Take All // Blog

How Pharmaceutical Incumbents Stifle Innovation and Inhibit Disruptors

Alex, Nick, and guest speaker D.A. Wallach discuss some of the disreputable ways incumbents in the pharmaceutical industry stifle innovation and inhibit disruptors. They go over methods including cutting off data flows and wielding the leverage of negotiated pricing across large portfolios.

Life Sciences Investor D.A. Wallach Interview: youtu.be/7BHofAqxn9c

Weekly Industry Newsletter

Top Posts

  • Platform Business Model – Definition | What is it? | Explanation

    Read more

  • Platform vs. Linear: Business Models 101

    Read more

  • Amazon Business Teardown

    Read more

  • The Value of Digital Transformation: How Investors Evaluate “Tech”

    Read more

  • What is a Venture Studio? | Definition and Examples

    Read more